{"prompt": "['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', 'SUSPICION OF RHABDOMYOLYSIS', 'Muscular symptoms (myalgia, pain, weakness,', 'Systematic CPK assessment as per', 'dark urines)', 'protocol', 'Perform CPK', 'If Increase in CPK (expressed in ULN)', '> 3 ULN', 'Repeat immediately the count.', 'If confirmed, inform the local monitor and', 'INVESTIGATE for the origin:', '- PERFORM:', 'ECG', 'CPK-MB -MM', 'Troponin', 'Creatinine', 'Iono (k+, Ca2+)', 'Transaminases + Total and conjugated bilirubin', 'Myoglobin (serum and urines)', '- COLLECT/STORE one sample following handling procedures described in PK sections (for', 'studies with PK sampling) and freeze one serum sample (5 mL) on Day 1 (cessation of', 'investigational medicinal product).', '- INTERVIEW the patient about a recent intensive muscular effort, trauma, convulsions, electrical', 'injury, injury or stress to the skeletal muscle, multiple intramuscular injections, recent surgery,', 'concomitant medications, consumption of alcohol, morphine, cocaine.', '- SEARCH for alternative causes to cardiac or muscular toxicity, ie: stroke, pulmonary infarction,', 'dermatomyositis or polymyositis, convulsions, hypothyroidism, delirium tremens, muscular', 'dystrophies.', 'If the cardiac origin or the rhabdomyolysis is', 'If either the cardiac origin or the', 'ruled out and if CPK < 10 ULN:', 'rhabdomyolysis is confirmed or if CPK', 'MONITOR CPK every 3 days for the first week', '> 10 ULN:', 'then once weekly until return to normal or for', '1. DISCONTINUE Investigational', 'at least 3 months', 'Medicinal Product administration', '2. MONITOR CPK every 3 days for the', 'first week then once weekly until return', 'to normal or for at least 3 months', '3. HOSPITALIZATION should be', 'considered', 'Suspicion of rhabdomyolysis is to be recorded as an AE only if at least 1 of the criteria in the', 'general guidelines for reporting adverse events in Section 10.4.3 is met.', 'Property of the Sanofi Group - strictly confidential', 'Page 101', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', 'Appendix B', 'Procedure for collection, handling, storage, and shipment of', 'SAR407899 specimens for pharmacogenetic samples', '1.', 'SUMMARY OF HANDLING AND SUPPLIES FOR PHARMACOGENETIC', 'SAMPLES', '1.1', 'Sampling Supply Description', 'Pharmacogenetic specimens', 'Collection/Storage Tube: 2 vacutainer BECTON Dickinson 6 mL K2 EDTA with', 'HEMOGARD closure,', '1.2', 'Summary of handling procedures for pharmacogenetic samples', 'Sample type(s)', 'Pharmacogenetic', 'Blood sample volume', '6 mL', 'Collection tube', 'a 6 mL Becton Dickinson K2 EDTA VACUTAINERTM Plus tubes with HEMOGARD TM closure', '(PN367863/4) sterile tubes', 'Anticoagulant', 'K2 EDTA', 'Blood handling procedures', 'Keep blood on ice and frozen within 30 minutes of sampling time. DO NOT CENTRIFUGE', 'BLOOD', 'Storage conditions', '-70\u00b0C or colder', '2.', 'COLLECTION/HANDLING/PROCESSING OF SAMPLES', 'The analytical methods used are extremely sensitive. All sampling procedures must be', 'followed accurately.', '2.1', 'Blood pharmacogenetic samples for DNA storage', 'Collection schedule: Per protocol.', 'Procedure:', '-', 'Using a waterproof pen, write subject ID on label in space provided,', '-', 'Collect 6 mL of blood, using the 6 mL Vacutainer Becton Dickinson K2 EDTA with', 'HEMOGARD Closure provided, and gently invert tube 10-15 times permitting the', 'specimen to mix with the anticoagulant,', '-', 'Under no circumstances should the tube be centrifuged,', '-', 'Ensure the sample tube is clearly and appropriately labeled as described above and in', 'detail in Covance laboratory manual,', '-', 'Immediately freeze and maintain the blood in an upright position at -70\u00b0C or colder.', 'Samples must be stored on dry ice if a freezer is not immediately available,', '-', 'Complete the laboratory requisition form (provided by Covance) for each sample.', 'Property of the Sanofi Group - strictly confidential', 'Page 102', '(electronic 4.0)']\n\n###\n\n", "completion": "END"}